FRANKLIN, Mass., May 10, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing its needle-freeSymphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., CEO, President
Dr. Mooney will make a corporate presentation to prospective corporate partners and investors on Monday, May 16th at 1:30PM EDT. The Company's presentation will be delivered at the Hard Rock Hotel in Hollywood, Florida.
At the time of the presentation, a live audio and high-definition video webcast of Echo Therapeutics' presentation and a copy of the presentation materials will be available on the Company's website www.echotx.com on the Events page or through the Noble Financial websites: www.noblefcm.com or www.noble7.com. Echo Therapeutics recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast and presentation will also be archived on www.echotx.com for 30 days following the event.
About Echo Therapeutics
Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.
About Noble Financial
Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service, investment banking boutique focused on small-cap, emerging growth companies. The company has offices in New York, Boston, New Jersey, St. Louis, and Boca Raton. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in late Spring featuring 120 – 150 presenting companies from across North America and total attendance of close to 600. For more information: www.noblefcm.com.
For More Information:
Patrick T. Mooney, M.D. Chairman and Chief Executive Officer(508)530-0329
Media: Richard SternStern & Co.(212) 888-0044
SOURCE Echo Therapeutics, Inc.
Subscribe to our Free Newsletters!
Soft tissue sarcoma is a rare cancer of connective tissue that can affect soft tissues such as fat, ...
To get rid of facial fat on cheek and chin, practice face yoga, eat right and keep your body ...
Bicuspid aortic valve is a congenital condition where the aortic valve has only two leaflets ...View All